Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for U.S. Food and Drug Administration approval and postmarket surveillance of endoscopic devices.

PMID: 32750323 ·

N, a, s, i, r, , S, a, l, e, e, m, ;, , M, o, h, a, m, m, a, d, , K, , I, s, m, a, i, l, ;, , C, l, a, u, d, i, o, , R, , T, o, m, b, a, z, z, i, ;, , S, a, r, t, h, a, k, , S, o, i, n, ;, , S, a, n, k, e, t, , S, , D, h, r, u, v, a

RevistaGastrointestinal endoscopy
Ano
PMID32750323

Resumo

Since the first widely reported case cluster of duodenoscope-associated transmission of carbapenem-resistant Enterobacteriaceae (CRE) in 2013 that affected 38 patients, similar outbreaks have occurred throughout the world. The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention, professional gastroenterology societies, and endoscope manufacturers have taken multiple steps to address this issue. Unlike prior outbreaks attributed to lapses in cleaning and reprocessi

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑